Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Minnesota
Phase 3: This descriptive study will use a between subjects, double blind design. This study will test 3 nicotine levels of nicotine, tar and ventilation. Subjects and research assistants will be blind to the cigarette type.
Age
18–64
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
18-64 years old
Regular smokers (10+ cigarettes per day and has done so for the last year)
Inhaling when smoking
Carbon monoxide (CO) \> 8 ppm
You may not be if
In the past year, suffered from any cardiovascular disease such as: heart disease, heart attack, stroke or angina, any respiratory diseases such as chronic bronchitis or chronic obstructive pulmonary disease (COPD), any type of cancer
Currently suffering from Bipolar Disorder, General Anxiety Disorder, Schizophrenia, or a major depressive episode
Taken any of the following drugs more than twice per week during the past month: antidepressants, anti-anxiety medications.
Consumed more than 15 alcoholic drinks per week for the past month
Pregnant, trying to become pregnant, or lactating (assessed by self-report)
In the past 3 months, used nicotine replacement products (like the patch, gum, or inhaler), or the medications bupropion varenicline
Currently trying or planning to reduce or quit tobacco use in the next 30 days
Used other forms of tobacco 10 or more days in the past 30 days
Clareo Health | Palatability of Experimental Cigarettes - Study 2
